1:33 PM
 | 
Jul 25, 2017
 |  BC Innovations  |  Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Obesity

In vitro and mouse studies suggest a modified NMU peptide that agonizes NMUR2 could help treat obesity. The agonist consisted of a PEGylated, eight amino acid from the NMU...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >